Collegium Pharmaceutical (COLL) Stock Analysis

What Collegium Pharmaceutical does

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy. The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respectively. Founded in 2002, the enterprise initially operated under the name Collegium Pharmaceuticals, Inc., before officially adopting its current identity as Collegium Pharmaceutical, Inc. in October 2003. The company's corporate headquarters are situated in Stoughton, Massachusetts.

Key metrics

ETFs linked to COLL

Broad-market and Healthcare sector ETFs an investor holding Collegium Pharmaceutical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how COLL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Collegium Pharmaceutical?

Collegium Pharmaceutical trades under the ticker COLL on NASDAQ.

Which exchange is COLL listed on?

COLL is listed on NASDAQ.

What sector does Collegium Pharmaceutical operate in?

Collegium Pharmaceutical is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze COLL in a portfolio?

PortView shows COLL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.